Racial disparities in breast cancer hereditary risk assessment referrals
- PMID: 32196827
- DOI: 10.1002/jgc4.1250
Racial disparities in breast cancer hereditary risk assessment referrals
Abstract
For poorly understood reasons, Black non-Hispanic (BNH) women meeting National Comprehensive Cancer Network (NCCN) criteria for genetic testing for breast cancer risk are less likely than White non-Hispanic (WNH) women to undergo testing (Armstrong, Micco, Carney, Stopfer, & Putt, JAMA, 293, 1729 and 2005). We compared physician referral rates and uptake for genetic testing of BNH and WNH women meeting select NCCN criteria (breast cancer under age 50, two primary breast cancers, triple-negative disease under age 60) in the Cancer Center at George Washington University (GWCC) between 2015 and 2018. Of the 723 BNH and WNH patients treated for breast cancer at GWCC, 28% met study criteria for genetic counseling referral (n = 252; BNH n = 115, WNH n = 137). Physician referral rates to genetic counseling differed significantly by race (BNH 75.7%, n = 87 and WNH 92.7%; n = 127; χ2 = 14.19, p-value < .01). Once referred, though, there was no significant difference in uptake of genetic counseling by race (BNH 95.4%, n = 83; WNH 97.6%, n = 124, χ2 = 1.33, p-value = .25) for patients appropriately referred.
Keywords: African-American; Black non-Hispanic; Breast cancer; D.C.; Washington; White Non-Hispanic; attitudes; disparities; genetic counseling; genetic testing; health disparities; hereditary risk assessment; risk management; underrepresented populations.
© 2020 National Society of Genetic Counselors.
References
REFERENCES
-
- Adams, I., Christopher, J., Williams, K. P., & Sheppard, V. B. (2015). What black women know and want to know about counseling and testing for BRCA1/2. Journal of Cancer Education, 30(2), 344-352.
-
- American Cancer Society (2017). Breast cancer facts & figures 2017-2018. Retrieved from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-....
-
- American College of Surgeons (2019). Commission on Cancer 2020 Standards, Optimal Resources for Cancer Care. Facs.org/cancer.
-
- Bates, B. R., Poiroit, K., Harris, T. M., Condit, C. M., & Achter, P. J. (2004). Evaluation direct-to-consumer marketing of race-based pharmacogenomics: A focus group study of public understandings of applied genomic medication. Journal of Health Communication, 9(6), 541-559.
-
- Brandon, D. T., Isaac, L. A., & LaVeist, T. A. (2005). The legacy of Tuskegee and trust in medical care: Is Tuskegee responsible for race differences in mistrust of medical care? Journal of the National Medical Association, 97(7), 951-956.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous